Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Lung inflammatory injury and tissue repair (Jul 2023)
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Signaling through estrogen receptors modulates telomerase activity in human prostate cancer
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Simona Nanni, … , Alfredo Pontecorvi, Antonella Farsetti
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):219-227. https://doi.org/10.1172/JCI15552.
View: Text | PDF
Article Genetics

Signaling through estrogen receptors modulates telomerase activity in human prostate cancer

  • Text
  • PDF
Abstract

Research Article

Authors

Simona Nanni, Michela Narducci, Linda Della Pietra, Fabiola Moretti, Annalisa Grasselli, Piero De Carli, Ada Sacchi, Alfredo Pontecorvi, Antonella Farsetti

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Induction of hTERT mRNA by E2 in normal and transformed human prostate e...
Induction of hTERT mRNA by E2 in normal and transformed human prostate epithelial cells. Total RNA was extracted from cells cultured in the presence or absence of E2 (10–7 M) for the indicated times. Semiquantitative RT-PCR analysis of hTERT and hTR mRNA levels was performed in (a) normal PrECs and fresh explants from two BPH lesions (no. 1 and 2), (b) three PCa specimens (no. 1, 2, and 3), and (c) three PCa cell lines (LNCaP, DU145, and PC-3). HeLa cell RNA (HeLa) and the “no cDNA template” (no DNA) were used as positive and negative controls, respectively. Densitometric analysis of hTERT and hTR mRNA levels in the presence or absence of E2 was performed after normalization to values obtained under the same conditions with the control housekeeping gene aldolase (ald). The average values from three independent experiments were expressed as the ratio of hTERT and hTR versus aldolase (hTERT/ald and hTR/ald) in a or as fold of induction (+/– E2) of normalized values (hTERT/ald and hTR/ald) in b and c.

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts